Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

XKON/066830 stock hub

XKON/066830 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XKON/066830is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.7B

Korea New Exchange

Market data

Live price

Current market quote for this ticker.

Current price

XKON/066830

In the news

Latest news · XKON/066830

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-25.6

P25 n/aP50 n/aP75 n/a

ROIC-7.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XKON/066830 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

157

Groups with data

Currency

KRW

Showing 157 of 157 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	KRW 6.7B
Price	KRW 1,190
Price currency	KRW
Sic	2836
Symbol	xkon/066830
Website	https://www.genotech.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-19.83%
FCF yield	1.88%
P/B ratio	1.39x
P/S ratio	0.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-13.9%
EBITDA Margin	-4.77%
FCF margin	1.72%
Gross margin	13.21%
Gross Profit	KRW 962.1M
Gross Profit Growth	-54.68%
Gross Profit Growth3 Y	-17.66%
Net Income	KRW -1.3B
Pretax Margin	-18.14%
Profit Margin	-18.14%
ROA	-4.12
Roa5y	-0.91
ROCE	-9.99
ROE	-25.6
Roe5y	-11.59
ROIC	-7.75
Roic5y	-1.58

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-20.15%
Cagr3y	-22.68%
Cagr5y	-18.21%
FCF Growth3 Y	-31.43%
OCF Growth	-2.08%
OCF Growth3 Y	-34.99%
Revenue Growth	11.35x
Revenue Growth3 Y	37.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.47
Assets	KRW 15.2B
Cash	KRW 1.2B
Current Assets	KRW 5B
Current Liabilities	KRW 5.1B
Debt	KRW 8.9B
Debt Equity	KRW 1.85
Debt FCF	KRW 70.91
Equity	KRW 4.8B
Interest Coverage	-2.64
Liabilities	KRW 10.4B
Long Term Assets	KRW 10.2B
Long Term Liabilities	KRW 5.3B
Net Cash	KRW -7.7B
Net Cash By Market Cap	KRW -115
Net Debt Equity	KRW 1.6
Net Debt FCF	KRW 61.24
Tangible Book Value	KRW 4.7B
Tangible Book Value Per Share	KRW 1,005
WACC	3.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.99
Inventory Turnover	2.13
Net Working Capital	KRW 3B
Quick ratio	0.49
Working Capital	KRW -55.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-20.13%
200-day SMA	1,170.6
3Y total return	-53.79%
50-day SMA	1,236.2
50-day SMA vs 200-day SMA	50over200
5Y total return	-63.38%
All Time High	7,430
All Time High Change	-83.98%
All Time High Date	2017-08-21
All Time Low	805
All Time Low Change	47.83%
All Time Low Date	2026-01-15
ATR	143.9
Beta	-0.09
Beta1y	-0.08
Beta2y	-0.15
Ch YTD	8.58
High	1,199
High52	1,600
High52 Date	2026-04-08
High52ch	-25.62%
Low	1,100
Low52	805
Low52 Date	2026-01-15
Low52ch	47.83%
Ma50ch	-3.74%
Price vs 200-day SMA	1.66%
RSI	46.68
RSI Monthly	42.4
RSI Weekly	50.28
Sharpe ratio	0.37x
Sortino ratio	0.59
Total Return	-9.92%
Tr YTD	8.58
Tr1m	-25.62%
Tr1w	-0.75%
Tr3m	20.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -1B
Operating margin	-13.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,872,650%
Net Borrowing	220,000,000
Shares Insiders	48.69%
Shares Institutions	2.76%
Shares Out	5,599,037

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 125.4M
Average Volume	1,488.4x
Bv Per Share	1,017.5
CAPEX	KRW -252.1M
Ch1m	-25.62
Ch1w	-0.75
Ch1y	-20.13
Ch3m	20.81
Ch3y	-53.79
Ch5y	-63.38
Ch6m	25.26
Change	0%
Change From Open	-0.75
Close	1,190
Days Gap	0.76
Depreciation Amortization	664,988,000
Dollar Volume	1,507,730
EBIT	KRW -1B
EBITDA	KRW -347.2M
EPS	KRW -280
F Score	3
FCF	KRW 125.4M
FCF Per Share	KRW 22.39
Financing CF	819,600,000
Fiscal Year End	December
Founded	1,997
Investing CF	-268,915,440
Is Primary Listing	1
Ma150	1,121
Ma150ch	6.16%
Ma20	1,303.9
Ma20ch	-8.73%
Net CF	928,093,700
Open	1,199
P FCF Ratio	53.15
P OCF Ratio	17.65
Position In Range	90.91
Ppne	8,332,455,210
Price Date	2026-05-08
Ptbv Ratio	1.4
Relative Volume	0.85x
Revenue	7,281,381,000x
Tr6m	25.26%
Volume	1,267
Z Score	-0.11

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does XKON/066830 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/066830 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XKON/066830?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.8%

Share of float held by funds and institutions

Insider ownership

+48.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

XKON/066830 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.7

Neutral momentum band

Price vs 200-day MA

+1.7%

50/200-day relationship not available

Beta (5Y)

-0.09

Less volatile than the market

Sharpe ratio

0.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About XKON/066830

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/066830 stock rating?

xkon/066830 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/066830 analysis?

The full report lives at /stocks/xkon/066830/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/066830?

The latest report frames xkon/066830 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/066830 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.